4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001193125-26-463787
Chief Financial Officer bought 20,000 shares at $0.86 ($17,100)
From the SEC's structured data for this filing
Trades in this filing
Howe Jill Ann · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Purchase : show line 1 in the form | +20,000 | $0.86 | $17,100 | 45,500 | D |
| Open-market purchases · 20,000 sh · avg $0.86 · $17,100 | ||||||
Loading xslF345X06/ownership.xml…